PBAC Public Summary Documents - July 2009
Public summary documents relating to the July 2009 PBAC meeting
Page last updated: 13 November 2009
- Ambrisentan, tablets, 5 mg and 10 mg, Volibris®
- Azacitidine, powder for injection, 100 mg, Vidaza®
- Bortezomib, powder for injection, 3.5 mg, 1 mg, Velcade®
- Calcipotriol with betamethasone dipropionate, ointment, 50 micrograms-500 micrograms (base) per g, Daivobet®
- Capecitabine, tablets, 150 mg and 500 mg, Xeloda®
- Cetuximab, solution for I.V. infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux®
- Cilostazol, tablets, 50 mg and 100 mg, Pletal®
- Cinacalcet hydrochloride, tablets, 30 mg, 60 mg and 90 mg, Sensipar®
- Dutasteride, capsule, 0.5 mg, Avodart®
- Hydroxyethyl starch 130/0.4, I.V. infusion, 60 g per L, 500 mL, Voluven® 6 %
- Influenza vaccine, injection in pre-filled syringe, 15 micrograms/strain/0.1 mL (containing A/New Caledonia/20/99, A/Wisconsin/67/2005, B/Malaysia/2506/2004 like strains), Intanza®
- Ivabradine hydrochloride, film coated tablets, 5 mg and 7.5 mg, Coralan®, July 2009
- Methylnaltrexone bromide, injection, 12 mg in 0.6 mL (base), Relistor®, July 2009
- Montelukast sodium, chewable tablets, 4 mg (base), chewable tablets 5 mg (base), and film coated tablet, 10 mg (base), Singulair®
- Olanzapine pamoate monohydrate, powder for injection with diluent vial, 210 mg, 300 mg and 405 mg, Zyprexa Relprevv®
- Pneumococcal polysaccharide conjugate vaccine, turbid liquid suspension for injection (0.5 mL) in pre-filled syringe or vial, Synflorix®
- Pramipexole hydrochloride, tablets, 125 micrograms, 250 micrograms, 1mg, Sifrol®
- Prasugrel hydrochloride, tablets, 5 mg (base) and 10 mg (base), Effient®, July 2009
- Romiplostim (RBE), powder for injection, 165 micrograms, 375 micrograms and 625 micrograms, Nplate®
- Sunitinib malate, capsules, 12.5 mg (base), 25 mg (base) and 50 mg (base), Sutent®, July 2009
- Tenofovir disoproxil fumarate, tablet, 300 mg, Viread®, July 2009
- Tocilizumab, solution for I.V. infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra®, July 2009
